$4.6 Billion is the total value of Eventide Asset Management's 134 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 29.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $252,887,000 | +32.2% | 1,709,848 | +0.7% | 5.50% | -11.3% |
| SRPT | SAREPTA THERAPEUTICS INC | $159,699,000 | +63.9% | 996,000 | 0.0% | 3.47% | +10.0% | |
| EXAS | Buy | EXACT SCIENCES CORP | $151,276,000 | +87.4% | 1,740,000 | +25.0% | 3.29% | +25.8% |
| IGV | Buy | ISHARES TRput | $137,700,000 | +122.2% | 600,000 | +106.2% | 2.99% | +49.2% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $130,411,000 | +114.8% | 1,783,761 | 0.0% | 2.84% | +44.2% | |
| FIVN | Sell | FIVE9 INC | $127,381,000 | +36.8% | 1,151,000 | -5.5% | 2.77% | -8.2% |
| TTD | THE TRADE DESK INC | $121,950,000 | +110.6% | 300,000 | 0.0% | 2.65% | +41.4% | |
| W | WAYFAIR INCcl a | $113,231,000 | +269.8% | 573,000 | 0.0% | 2.46% | +148.1% | |
| KRTX | KARUNA THERAPEUTICS INC | $100,434,000 | +54.8% | 901,077 | 0.0% | 2.18% | +3.9% | |
| CRWD | CROWDSTRIKE HLDGS INCcl a | $98,986,000 | +80.1% | 987,000 | 0.0% | 2.15% | +20.9% | |
| ROP | Buy | ROPER TECHNOLOGIES INC | $90,232,000 | +35.2% | 232,400 | +8.6% | 1.96% | -9.3% |
| PLRX | New | PLIANT THERAPEUTICS INC | $88,412,000 | – | 2,838,125 | +100.0% | 1.92% | – |
| TWLO | Sell | TWILIO INCcl a | $84,696,000 | +38.2% | 386,000 | -43.6% | 1.84% | -7.3% |
| LOW | Buy | LOWES COS INC | $81,058,000 | +57.9% | 599,900 | +0.6% | 1.76% | +6.0% |
| SPLK | Sell | SPLUNK INC | $75,506,000 | +39.8% | 380,000 | -11.2% | 1.64% | -6.2% |
| WCN | WASTE CONNECTIONS INC | $75,407,000 | +21.0% | 804,000 | 0.0% | 1.64% | -18.8% | |
| DT | Sell | DYNATRACE INC | $75,090,000 | +51.7% | 1,849,500 | -10.9% | 1.63% | +1.8% |
| MTD | Buy | METTLER TOLEDO INTERNATIONAL | $73,305,000 | +49.5% | 91,000 | +28.2% | 1.59% | +0.4% |
| POOL | Buy | POOL CORPORATION | $67,750,000 | +85.1% | 249,200 | +34.0% | 1.47% | +24.3% |
| LRCX | LAM RESEARCH CORP | $65,015,000 | +34.8% | 201,000 | 0.0% | 1.41% | -9.5% | |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $64,515,000 | +20.7% | 1,258,100 | +1.2% | 1.40% | -19.0% |
| ASML | ASML HOLDING N V | $63,301,000 | +40.7% | 172,000 | 0.0% | 1.38% | -5.6% | |
| MYOK | MYOKARDIA INC | $60,001,000 | +106.1% | 621,000 | 0.0% | 1.30% | +38.3% | |
| ARGX | Sell | ARGENX SEsponsored adr | $59,461,000 | +51.8% | 264,000 | -11.2% | 1.29% | +2.0% |
| LII | LENNOX INTL INC | $59,412,000 | +28.2% | 255,000 | 0.0% | 1.29% | -13.9% | |
| IDXX | Buy | IDEXX LABS INC | $58,108,000 | +67.7% | 176,000 | +23.1% | 1.26% | +12.6% |
| SMAR | Buy | SMARTSHEET INC | $56,674,000 | +44.2% | 1,113,000 | +17.5% | 1.23% | -3.2% |
| GWPH | GW PHARMACEUTICALS PLCads | $53,506,000 | +40.1% | 436,000 | 0.0% | 1.16% | -5.9% | |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $53,357,000 | -3.9% | 3,193,117 | -17.1% | 1.16% | -35.5% |
| IPHI | INPHI CORP | $52,875,000 | +48.4% | 450,000 | 0.0% | 1.15% | -0.4% | |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $52,607,000 | +87.7% | 310,200 | +45.3% | 1.14% | +26.1% |
| HUBS | Sell | HUBSPOT INC | $52,049,000 | +17.7% | 232,000 | -30.1% | 1.13% | -21.0% |
| TREX | Buy | TREX CO INC | $48,646,000 | +103.0% | 374,000 | +25.1% | 1.06% | +36.2% |
| VMC | Sell | VULCAN MATLS CO | $46,155,000 | +6.3% | 398,400 | -0.8% | 1.00% | -28.7% |
| RNG | Buy | RINGCENTRAL INCcl a | $44,177,000 | +72.3% | 155,000 | +28.1% | 0.96% | +15.7% |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $44,080,000 | +14.8% | 263,400 | -0.9% | 0.96% | -22.9% |
| BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $43,886,000 | +12.7% | 916,200 | 0.0% | 0.95% | -24.3% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $43,652,000 | +42.9% | 357,800 | +1.4% | 0.95% | -4.0% |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $42,496,000 | – | 914,705 | +100.0% | 0.92% | – |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $42,490,000 | +7.2% | 2,427,976 | 0.0% | 0.92% | -28.0% | |
| TT | Buy | TRANE TECHNOLOGIES PLC | $41,999,000 | +2468.7% | 472,000 | +2283.8% | 0.91% | +1622.6% |
| APTV | Sell | APTIV PLC | $41,843,000 | +52.7% | 537,000 | -3.5% | 0.91% | +2.6% |
| DHI | Buy | D R HORTON INC | $40,490,000 | +80.7% | 730,200 | +10.8% | 0.88% | +21.2% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $40,323,000 | +22.3% | 1,212,000 | 0.0% | 0.88% | -17.9% | |
| VRSK | Buy | VERISK ANALYTICS INC | $37,359,000 | +69.6% | 219,500 | +38.9% | 0.81% | +13.9% |
| KALA | Buy | KALA PHARMACEUTICALS INC | $36,259,000 | +39.7% | 3,450,000 | +16.8% | 0.79% | -6.3% |
| BPMC | BLUEPRINT MEDICINES CORP | $36,036,000 | +33.4% | 462,000 | 0.0% | 0.78% | -10.5% | |
| MRTX | MIRATI THERAPEUTICS INC | $34,365,000 | +48.5% | 301,000 | 0.0% | 0.75% | -0.3% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $33,775,000 | +23.6% | 535,000 | 0.0% | 0.73% | -17.1% | |
| AVRO | AVROBIO INC | $33,248,000 | +12.1% | 1,905,307 | 0.0% | 0.72% | -24.7% | |
| MGA | Buy | MAGNA INTL INC | $32,716,000 | +42.7% | 734,700 | +2.3% | 0.71% | -4.2% |
| ZGNX | Sell | ZOGENIX INC | $32,717,000 | -53.4% | 1,211,300 | -57.4% | 0.71% | -68.7% |
| PANW | PALO ALTO NETWORKS INC | $32,576,000 | +40.1% | 141,837 | 0.0% | 0.71% | -6.0% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $32,442,000 | +64.4% | 1,550,000 | +9.5% | 0.70% | +10.3% |
| NOVT | NOVANTA INC | $29,896,000 | +33.7% | 280,000 | 0.0% | 0.65% | -10.2% | |
| FVRR | New | FIVERR INTL LTD | $29,402,000 | – | 398,299 | +100.0% | 0.64% | – |
| DDOG | DATADOG INC | $28,607,000 | +141.7% | 329,000 | 0.0% | 0.62% | +62.4% | |
| STSA | SATSUMA PHARMACEUTICALS INC | $28,282,000 | +37.5% | 983,382 | 0.0% | 0.62% | -7.7% | |
| ROL | Sell | ROLLINS INC | $27,087,000 | -3.0% | 639,000 | -17.3% | 0.59% | -34.9% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $24,738,000 | – | 383,000 | +100.0% | 0.54% | – |
| VCYT | VERACYTE INC | $24,087,000 | +6.5% | 930,000 | 0.0% | 0.52% | -28.4% | |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $23,881,000 | +38.5% | 839,100 | -0.7% | 0.52% | -7.0% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $23,599,000 | +69.5% | 1,347,000 | +42.2% | 0.51% | +13.7% |
| QURE | UNIQURE NV | $22,530,000 | -5.0% | 500,000 | 0.0% | 0.49% | -36.2% | |
| OKTA | OKTA INCcl a | $21,625,000 | +63.8% | 108,000 | 0.0% | 0.47% | +9.8% | |
| CGNX | New | COGNEX CORP | $21,439,000 | – | 359,000 | +100.0% | 0.47% | – |
| AY | Sell | ATLANTICA SUSTAINABLE INFR P | $21,418,000 | +11.5% | 736,000 | -14.6% | 0.47% | -25.1% |
| New | TRILLIUM THERAPEUTICS INC | $20,605,000 | – | 2,547,000 | +100.0% | 0.45% | – | |
| KALV | KALVISTA PHARMACEUTICALS INC | $20,328,000 | +58.2% | 1,680,000 | 0.0% | 0.44% | +6.2% | |
| MDB | MONGODB INCcl a | $19,465,000 | +65.8% | 86,000 | 0.0% | 0.42% | +11.3% | |
| REGN | REGENERON PHARMACEUTICALS | $19,271,000 | +27.7% | 30,900 | 0.0% | 0.42% | -14.3% | |
| SWKS | Buy | SKYWORKS SOLUTIONS INC | $18,949,000 | +56.8% | 148,200 | +9.6% | 0.41% | +5.4% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $17,721,000 | +57.7% | 2,359,646 | +31.8% | 0.38% | +5.8% |
| SGEN | SEATTLE GENETICS INC | $17,417,000 | +47.3% | 102,500 | 0.0% | 0.38% | -1.0% | |
| XPO | XPO LOGISTICS INC | $16,995,000 | +58.5% | 220,000 | 0.0% | 0.37% | +6.3% | |
| XENE | XENON PHARMACEUTICALS INC | $15,977,000 | +10.6% | 1,274,100 | 0.0% | 0.35% | -25.9% | |
| BLU | New | BELLUS HEALTH INC NEW | $15,877,000 | – | 1,543,000 | +100.0% | 0.34% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $15,411,000 | +17.5% | 1,985,975 | +54.4% | 0.34% | -21.2% |
| IMVT | New | IMMUNOVANT INC | $15,242,000 | – | 625,950 | +100.0% | 0.33% | – |
| PHAT | PHATHOM PHARMACEUTICALS INC | $14,809,000 | +27.5% | 450,000 | 0.0% | 0.32% | -14.4% | |
| RGEN | REPLIGEN CORP | $14,710,000 | +28.0% | 119,000 | 0.0% | 0.32% | -14.0% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $14,512,000 | +45.1% | 243,000 | 0.0% | 0.32% | -2.8% | |
| CIEN | New | CIENA CORP | $14,461,000 | – | 267,000 | +100.0% | 0.31% | – |
| ISRG | INTUITIVE SURGICAL INC | $14,246,000 | +15.1% | 25,000 | 0.0% | 0.31% | -22.7% | |
| XLRN | ACCELERON PHARMA INC | $13,614,000 | +6.0% | 142,900 | 0.0% | 0.30% | -28.8% | |
| LW | Sell | LAMB WESTON HLDGS INC | $13,336,000 | -3.6% | 208,600 | -13.9% | 0.29% | -35.3% |
| VRTX | VERTEX PHARMACEUTICALS INC | $13,209,000 | +22.0% | 45,500 | 0.0% | 0.29% | -18.2% | |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $12,592,000 | – | 800,000 | +100.0% | 0.27% | – |
| EPIX | ESSA PHARMA INC | $11,840,000 | +55.0% | 2,010,169 | 0.0% | 0.26% | +4.0% | |
| ALLK | ALLAKOS INC | $11,498,000 | +61.5% | 160,000 | 0.0% | 0.25% | +8.2% | |
| ETNB | Buy | 89BIO INC | $11,460,000 | +29.7% | 575,000 | +64.3% | 0.25% | -12.9% |
| MKC | MCCORMICK & CO INC | $10,765,000 | +27.1% | 60,000 | 0.0% | 0.23% | -14.6% | |
| EIDX | EIDOS THERAPEUTICS INC | $10,154,000 | -2.7% | 213,000 | 0.0% | 0.22% | -34.6% | |
| GLPG | GALAPAGOS NVspon adr | $10,062,000 | +0.7% | 51,000 | 0.0% | 0.22% | -32.4% | |
| CCXI | New | CHEMOCENTRYX INC | $10,069,000 | – | 175,000 | +100.0% | 0.22% | – |
| XNCR | XENCOR INC | $9,717,000 | +8.4% | 300,000 | 0.0% | 0.21% | -27.2% | |
| FENC | Buy | FENNEC PHARMACEUTICALS INC | $9,352,000 | +118.7% | 1,120,000 | +55.6% | 0.20% | +46.0% |
| ARVN | ARVINAS INC | $7,714,000 | -16.8% | 230,000 | 0.0% | 0.17% | -44.0% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $7,299,000 | +193.5% | 492,500 | +117.3% | 0.16% | +96.3% |
| ADCT | New | ADC THERAPEUTICS SA | $7,021,000 | – | 150,000 | +100.0% | 0.15% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $6,023,000 | – | 463,335 | +100.0% | 0.13% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $5,779,000 | +71.3% | 65,400 | +38.9% | 0.13% | +15.6% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $5,387,000 | +63.1% | 33,200 | +37.8% | 0.12% | +9.3% |
| CHMA | New | CHIASMA INC | $5,186,000 | – | 964,000 | +100.0% | 0.11% | – |
| PLD | Buy | PROLOGIS INC. | $4,722,000 | +49.5% | 50,600 | +28.8% | 0.10% | +1.0% |
| NEE | Buy | NEXTERA ENERGY INC | $4,587,000 | +9.6% | 19,100 | +9.8% | 0.10% | -26.5% |
| JKHY | Buy | HENRY JACK & ASSOC INC | $4,472,000 | +29.8% | 24,300 | +9.5% | 0.10% | -13.4% |
| TER | Buy | TERADYNE INC | $3,769,000 | +128.8% | 44,600 | +46.7% | 0.08% | +54.7% |
| WM | Buy | WASTE MGMT INC DEL | $3,792,000 | +35.2% | 35,800 | +18.2% | 0.08% | -9.9% |
| EQIX | Sell | EQUINIX INC | $3,722,000 | -14.9% | 5,300 | -24.3% | 0.08% | -43.0% |
| ITT | New | ITT INC | $3,654,000 | – | 62,200 | +100.0% | 0.08% | – |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $3,413,000 | +237.3% | 32,200 | +161.8% | 0.07% | +124.2% |
| Buy | EXACT SCIENCES CORPnote 1.000% 1/1 | $3,303,000 | +315.5% | 2,411,000 | +230.3% | 0.07% | +176.9% | |
| AWK | New | AMERICAN WTR WKS CO INC NEW | $3,229,000 | – | 25,100 | +100.0% | 0.07% | – |
| FHN | New | FIRST HORIZON NATL CORP | $3,229,000 | – | 324,200 | +100.0% | 0.07% | – |
| CMS | Sell | CMS ENERGY CORP | $3,102,000 | -24.2% | 53,100 | -23.8% | 0.07% | -49.6% |
| STE | New | STERIS PLC | $2,946,000 | – | 19,200 | +100.0% | 0.06% | – |
| SHW | Buy | SHERWIN WILLIAMS CO | $2,831,000 | +43.3% | 4,900 | +14.0% | 0.06% | -3.1% |
| TCF | New | TCF FINANCIAL CORPORATION NE | $2,742,000 | – | 93,200 | +100.0% | 0.06% | – |
| WEC | Sell | WEC ENERGY GROUP INC | $2,708,000 | -23.0% | 30,900 | -22.6% | 0.06% | -48.2% |
| KLAC | Sell | KLA CORP | $2,606,000 | +15.5% | 13,400 | -14.6% | 0.06% | -21.9% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $2,530,000 | +64.7% | 21,200 | +39.5% | 0.06% | +10.0% |
| ETTX | ENTASIS THERAPEUTICS HLDGS I | $2,473,000 | +16.0% | 879,541 | 0.0% | 0.05% | -21.7% | |
| ARYAW | New | ARYA SCIENCES ACQUISITION CO*w exp 10/10/202 | $2,140,000 | – | 400,000 | +100.0% | 0.05% | – |
| AQN | Sell | ALGONQUIN PWR UTILS CORP | $1,918,000 | -49.8% | 148,200 | -48.1% | 0.04% | -66.1% |
| ZTS | ZOETIS INCcl a | $1,946,000 | +16.5% | 14,200 | 0.0% | 0.04% | -22.2% | |
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,818,000 | +30.0% | 1,087,000 | 0.0% | 0.04% | -11.1% | ||
| MSCI | New | MSCI INC | $1,202,000 | – | 3,600 | +100.0% | 0.03% | – |
| IEX | Sell | IDEX CORP | $1,169,000 | -9.0% | 7,400 | -20.4% | 0.02% | -40.5% |
| NDAQ | New | NASDAQ INC | $920,000 | – | 7,700 | +100.0% | 0.02% | – |
| SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $882,000 | +51.0% | 384,000 | 0.0% | 0.02% | 0.0% | ||
| ENTG | New | ENTEGRIS INC | $844,000 | – | 14,300 | +100.0% | 0.02% | – |
| BRBR | New | BELLRING BRANDS INC | $558,000 | – | 28,000 | +100.0% | 0.01% | – |
| ELS | Sell | EQUITY LIFESTYLE PPTYS INC | $306,000 | -85.9% | 4,900 | -87.0% | 0.01% | -90.0% |
| CCOI | Exit | COGENT COMMUNICATIONS HLDGS | $0 | – | -3,100 | -100.0% | -0.01% | – |
| CCIPRA | Exit | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $0 | – | -320 | -100.0% | -0.01% | – |
| IMVTW | Exit | IMMUNOVANT INC*w exp 12/18/202 | $0 | – | -651,900 | -100.0% | -0.05% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -270,000 | -100.0% | -0.07% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -800,000 | -100.0% | -0.20% | – |
| ARYAU | Exit | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $0 | – | -800,000 | -100.0% | -0.29% | – |
| CTAS | Exit | CINTAS CORP | $0 | – | -111,000 | -100.0% | -0.62% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -4,160,608 | -100.0% | -0.65% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -790,000 | -100.0% | -0.74% | – |
| VRNS | Exit | VARONIS SYS INC | $0 | – | -420,000 | -100.0% | -0.87% | – |
| W | Exit | WAYFAIR INCcall | $0 | – | -250,000 | -100.0% | -0.97% | – |
| XYL | Exit | XYLEM INC | $0 | – | -793,000 | -100.0% | -1.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.